Edition:
United Kingdom

Globus Medical Inc (GMED.N)

GMED.N on New York Stock Exchange

43.83USD
2:32pm GMT
Change (% chg)

$0.33 (+0.76%)
Prev Close
$43.50
Open
$43.77
Day's High
$43.83
Day's Low
$43.77
Volume
7,479
Avg. Vol
182,712
52-wk High
$46.51
52-wk Low
$25.68

Chart for

About

Globus Medical, Inc. is a medical device company. The Company is focused on developing products for patients with musculoskeletal disorders. It is focused on products to treat patients with spine disorders. The Company's products fall under categories, which include Innovative Fusion and Disruptive Technologies. The Innovative... (more)

Overall

Beta: 0.55
Market Cap(Mil.): $3,006.23
Shares Outstanding(Mil.): 96.29
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 32.28 16.58
EPS (TTM): -- -- --
ROI: -- 13.90 10.60
ROE: -- 16.71 14.19

BRIEF-Globus Medical Expects Q4 Sales Of About $175.5 mln

* GLOBUS MEDICAL REPORTS PRELIMINARY FOURTH QUARTER AND FULL YEAR SALES RESULTS

09 Jan 2018

BRIEF-Globus Medical sees Q4 2017 sales about $175.5 million

* GLOBUS MEDICAL REPORTS PRELIMINARY FOURTH QUARTER AND FULL YEAR SALES RESULTS

09 Jan 2018

BRIEF-Globus Medical reports Q3 earnings per share $0.26

* Q3 earnings per share view $0.30 -- Thomson Reuters I/B/E/S

08 Nov 2017

BRIEF-Globus Medical ‍expects first revenues from sale of ExcelsiusGPS systems in Q4 2017

* Globus Medical announces first spine surgeries using ExcelsiusGPS

10 Oct 2017

BRIEF-Globus Medical appoints David Demski as CEO

* Globus Medical Inc - ‍Paul will remain in role of executive chairman​

29 Aug 2017

BRIEF-Globus Medical announces FDA 510(k) clearance for Excelsius GPS

* Globus Medical announces FDA 510(k) clearance for Excelsius GPS™ Source text for Eikon: Further company coverage:

17 Aug 2017

Earnings vs. Estimates